Free shipping on all orders over $ 500

 About 1 result found for searched term "1934259-00-3" (0.192 seconds)

Cat.No.  Name Target
M13437 ASK120067 EGFR/HER2
Limertinib
ASK120067 is the third generation EGFR-TKI for non-small cell lung cancer (NSCLC) studies and is an effective oral EGFRT790M inhibitor (IC50 = 0.3 nM) with EGFRWT selectivity (IC50 = 6.0 nM).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.